Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$268.26 - $339.48 $121,521 - $153,784
-453 Reduced 3.91%
11,141 $3.04 Million
Q1 2024

May 03, 2024

SELL
$304.11 - $351.99 $29,802 - $34,495
-98 Reduced 0.84%
11,594 $4.01 Million
Q4 2023

Jan 24, 2024

SELL
$269.37 - $365.04 $12,929 - $17,521
-48 Reduced 0.41%
11,692 $3.78 Million
Q3 2023

Oct 23, 2023

SELL
$350.25 - $422.63 $188,784 - $227,797
-539 Reduced 4.39%
11,740 $4.21 Million
Q2 2023

Jul 25, 2023

SELL
$359.49 - $486.4 $83,761 - $113,331
-233 Reduced 1.86%
12,279 $4.66 Million
Q1 2023

May 17, 2023

BUY
$418.69 - $503.0 $5.24 Million - $6.29 Million
12,512 New
12,512 $5.99 Million
Q4 2022

Feb 09, 2023

SELL
$351.71 - $456.01 $248,658 - $322,399
-707 Reduced 5.4%
12,385 $5.21 Million
Q3 2022

Nov 04, 2022

BUY
$412.59 - $563.26 $6,601 - $9,012
16 Added 0.12%
13,092 $5.46 Million
Q2 2022

Aug 10, 2022

BUY
$463.67 - $597.16 $37,557 - $48,369
81 Added 0.62%
13,076 $6.47 Million
Q1 2022

Apr 27, 2022

BUY
$524.57 - $735.42 $19,409 - $27,210
37 Added 0.29%
12,995 $7.32 Million
Q4 2021

Jan 31, 2022

SELL
$708.84 - $794.68 $168,703 - $189,133
-238 Reduced 1.8%
12,958 $9.79 Million
Q3 2021

Oct 20, 2021

SELL
$657.71 - $825.77 $353,847 - $444,264
-538 Reduced 3.92%
13,196 $9.84 Million
Q2 2021

Jul 20, 2021

SELL
$576.64 - $649.04 $419,793 - $472,501
-728 Reduced 5.03%
13,734 $8.85 Million
Q1 2021

Apr 22, 2021

SELL
$547.01 - $662.35 $565,061 - $684,207
-1,033 Reduced 6.67%
14,462 $8.26 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $186,398 - $234,859
-365 Reduced 2.3%
15,495 $9.03 Million
Q3 2020

Nov 06, 2020

SELL
$454.43 - $535.6 $608,936 - $717,704
-1,340 Reduced 7.79%
15,860 $8.18 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $5.76 Million - $8.48 Million
17,200 New
17,200 $7.77 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.42B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.